| Issue |
Section |
Title |
File |
| Vol 16, No 3 (2017) |
Статьи |
The results of pilot trial ALL-REZ-MВ-2014 for children with relapsed acute lymphoblastic leukemia |
(Rus)
|
| Vol 14, No 1 (2015) |
ОСТРЫЙ ЛИМФОБЛАСТНЫЙ ЛЕЙКОЗ |
Therapy of childhood T-cell acute lymphoblastic leukemia: Experience gained by the Russian-Byelorussian cooperative group |
(Rus)
|
| Vol 14, No 3 (2015) |
CLINICAL OBSERVATIONS |
A clinical case report of acute intermittent porphyria in a patient aged 9 years |
(Rus)
|
| Vol 19, No 3 (2020) |
CLINICAL OBSERVATIONS |
Cases of transient abnormal myelopoiesis |
(Rus)
|
| Vol 19, No 3 (2020) |
CLINICAL OBSERVATIONS |
When the disease goes beyond the skin, changes in the skin can be a sign of systemic disease |
(Rus)
|
| Vol 20, No 1 (2021) |
CLINICAL OBSERVATIONS |
Repidly involuting congenital hemangioma |
(Rus)
|
| Vol 20, No 1 (2021) |
LITERATURE REVIEW |
Infantile hemangioma explained in simple terms |
(Rus)
|
| Vol 20, No 2 (2021) |
LITERATURE REVIEW |
Modern treatment of infantile hemangioma |
(Rus)
|
| Vol 20, No 3 (2021) |
ORIGINAL ARTICLES |
Kaposiform hemangioendothelioma/Kasabach–Merritt syndrome. Сlinical and laboratory characteristics. Analysis of clinical cases |
(Rus)
|
| Vol 20, No 4 (2021) |
CLINICAL OBSERVATIONS |
Giant cell angioblastoma |
(Rus)
|
| Vol 21, No 1 (2022) |
ORIGINAL ARTICLES |
The outcomes of children with acute myeloid leukemia treated in accordance with the AML–MM-2006 protocol |
(Rus)
|
| Vol 21, No 1 (2022) |
CLINICAL OBSERVATIONS |
New approaches for solving the old problem |
(Rus)
|
| Vol 21, No 3 (2022) |
CLINICAL OBSERVATIONS |
Multifocal lymphangioendotheliomatosis with thrombocytopenia/cutaneovisceral angiomatosis with thrombocytopenia |
(Rus)
|
| Vol 21, No 3 (2022) |
CLINICAL OBSERVATIONS |
Acute lymphoblastic leukemia with the t(17;19) translocation: hope has appeared! Multimodal immunotherapy in a 3-year-old child with refractory disease: a case report |
(Rus)
|
| Vol 22, No 1 (2023) |
ORIGINAL ARTICLES |
The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 22, No 2 (2023) |
ORIGINAL ARTICLES |
The results of therapy in patients with high-risk neuroblastoma: the experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology |
(Rus)
|
| Vol 22, No 2 (2023) |
CLINICAL OBSERVATIONS |
Kaposiform lymphangiomatosis with Kasabach–Merritt phenomenon |
(Rus)
|
| Vol 22, No 4 (2023) |
ORIGINAL ARTICLES |
Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia |
(Rus)
|
| Vol 23, No 1 (2024) |
ORIGINAL ARTICLES |
Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol |
(Rus)
|
| Vol 23, No 4 (2024) |
ORIGINAL ARTICLES |
Thrombocytopenia of newborns: an observational study |
(Rus)
|
| Vol 23, No 4 (2024) |
ORIGINAL ARTICLES |
Transient abnormal myelopoiesis, myelodysplastic syndrome and acute myeloid leukemia in children with Down syndrome |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Pediatric non-Down syndrome acute megakaryoblastic leukemia with GATA1 mutations |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Preliminary results of treatment of intermediate-risk patients according to the AML-MRD-2018 protocol |
(Rus)
|
| Vol 24, No 1 (2025) |
ORIGINAL ARTICLES |
Pegylated asparaginase during induction therapy in children with intermediate-risk acute lymphoblastic leukemia: results of a randomized study |
(Rus)
|
